FONTANA: A Modular Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination with Anti-cancer Agents in Participants with Solid Tumors

Is this Study for You?

Let's Get Started!




CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Lindsay Brubaker

Lindsay Brubaker

Study ID

Protocol Number: 23-2128

More information available at NCT05797168

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers